GENEREX BIOTECHNOLOGY CORP: 10-K filed 2014-10-03
What GENEREX BIOTECHNOLOGY CORP reported in its annual report filed 2014-10-03 (fiscal FY 2014): 30 published measures, 74 facts as tagged in accession 0001607062-14-000128.
This filing
- Form
- 10-K (annual report)
- Filed
- 2014-10-03
- Fiscal period
- fiscal FY 2014
- Accession
- 0001607062-14-000128 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All GENEREX BIOTECHNOLOGY CORP filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-07-31 | 5,522,457 | USD | |
| At 2013-07-31 | 4,852,863 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-07-31 | 11,612,515 | USD | |
| At 2013-07-31 | 14,994,195 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-07-31 | -6,090,058 | USD | |
| At 2013-07-31 | -10,141,332 | USD | |
| At 2012-07-31 | -8,380,190 | USD | |
| At 2011-07-31 | -8,442,136 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-07-31 | 3,269,489 | USD | |
| At 2013-07-31 | 1,708,954 | USD | |
| At 2012-07-31 | 246,309 | USD | |
| At 2011-07-31 | 2,798,797 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-08-01 to 2014-07-31 | -1,417 | USD | 365 |
| 2012-08-01 to 2013-07-31 | -8,554,322 | USD | 365 |
| 2011-08-01 to 2012-07-31 | -9,490,278 | USD | 366 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-08-01 to 2014-07-31 | -3,573,625 | USD | 365 |
| 2012-08-01 to 2013-07-31 | -3,661,234 | USD | 365 |
| 2011-08-01 to 2012-07-31 | -8,043,979 | USD | 366 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-08-01 to 2012-07-31 | 2,416 | USD | 366 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-08-01 to 2014-07-31 | 4,350,664 | USD | 365 |
| 2012-08-01 to 2013-07-31 | 3,461,158 | USD | 365 |
| 2011-08-01 to 2012-07-31 | 746,477 | USD | 366 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-08-01 to 2014-07-31 | 794,299 | USD | 365 |
| 2012-08-01 to 2013-07-31 | 1,685,060 | USD | 365 |
| 2011-08-01 to 2012-07-31 | 4,777,134 | USD | 366 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-07-31 | -370,000,000 | USD |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-07-31 | 5,293 | USD | |
| At 2013-07-31 | 85,406 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-08-01 to 2014-07-31 | 262,871 | USD | 365 |
| 2012-08-01 to 2013-07-31 | 837,753 | USD | 365 |
| 2011-08-01 to 2012-07-31 | 602,384 | USD | 366 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-08-01 to 2014-07-31 | -4,399,679 | USD | 365 |
| 2012-08-01 to 2013-07-31 | -6,129,359 | USD | 365 |
| 2011-08-01 to 2012-07-31 | -10,024,048 | USD | 366 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-07-31 | 3,470,803 | USD | |
| At 2013-07-31 | 1,807,269 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-08-01 to 2014-07-31 | 321,670 | USD | 365 |
| 2012-08-01 to 2013-07-31 | 530,222 | USD | 365 |
| 2011-08-01 to 2012-07-31 | 592,525 | USD | 366 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-07-31 | 8,257,784 | USD | |
| At 2013-07-31 | 8,503,742 | USD |
Net finite-lived intangible assets
Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-07-31 | 2,046,361 | USD | |
| At 2013-07-31 | 2,319,416 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-08-01 to 2014-07-31 | 4,399,679 | USD | 365 |
| 2012-08-01 to 2013-07-31 | 6,129,359 | USD | 365 |
| 2011-08-01 to 2012-07-31 | 10,041,590 | USD | 366 |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-08-01 to 2012-07-31 | 17,542 | USD | 366 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-08-01 to 2014-07-31 | 1,382,995 | USD | 365 |
| 2012-08-01 to 2013-07-31 | 2,192,724 | USD | 365 |
| 2011-08-01 to 2012-07-31 | 4,987,236 | USD | 366 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-07-31 | 778,512,092 | shares | |
| At 2013-07-31 | 580,329,160 | shares |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-07-31 | 772,074 | USD | |
| At 2013-07-31 | 765,103 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-07-31 | 13,078 | USD | |
| At 2013-07-31 | 507,939 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-07-31 | 7,785 | USD | |
| At 2013-07-31 | 422,533 | USD |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-08-01 to 2014-07-31 | -1,417 | USD | 365 |
| 2012-08-01 to 2013-07-31 | -8,554,322 | USD | 365 |
| 2011-08-01 to 2012-07-31 | -9,490,278 | USD | 366 |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-08-01 to 2014-07-31 | -2,059,746 | USD | 365 |
| 2012-08-01 to 2013-07-31 | -10,276,796 | USD | 365 |
| 2011-08-01 to 2012-07-31 | -9,867,024 | USD | 366 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-08-01 to 2014-07-31 | 3,016,684 | USD | 365 |
| 2012-08-01 to 2013-07-31 | 3,936,635 | USD | 365 |
| 2011-08-01 to 2012-07-31 | 4,889,179 | USD | 366 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-08-01 to 2014-07-31 | 10,482 | USD | 365 |
| 2012-08-01 to 2013-07-31 | 41,890 | USD | 365 |
| 2011-08-01 to 2012-07-31 | 97,967 | USD | 366 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-08-01 to 2014-07-31 | 368,447 | USD | 365 |
| 2012-08-01 to 2013-07-31 | 463,718 | USD | 365 |
| 2011-08-01 to 2012-07-31 | 612,658 | USD | 366 |
Amortization of intangible assets
Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-08-01 to 2012-07-31 | 440,780 | USD | 366 |
Inspect the source
- Entity
- GENEREX BIOTECHNOLOGY CORP / CIK 0001059784
- Captured
- SEC response SHA-256
a8779b8c3aa8286320834b30d50af09999238cecacb9e7883d21e11477763a4d
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001059784.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))